Safran SA (OTCMKTS:SAFRY – Get Free Report) saw unusually-strong trading volume on Monday. 493,074 shares changed hands during mid-day trading, an increase of 98% from the average daily volume of 248,524 shares. The stock last traded at $80.55 and had previously closed at $76.63.
Analysts Set New Price Targets
Several equities analysts recently commented on the company. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Safran in a research report on Wednesday, July 29th. DZ Bank raised shares of Safran from a “hold” rating to a “strong-buy” rating in a research report on Thursday. Jefferies Financial Group restated a “hold” rating on shares of Safran in a research note on Thursday, August 13th. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Safran in a research report on Monday, October 26th. Finally, Citigroup reaffirmed a “neutral” rating on shares of Safran in a research report on Wednesday. Two research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Safran has an average rating of “Moderate Buy”.
Check Out Our Latest Report on Safran
Safran Price Performance
The company has a debt-to-equity ratio of 0.19, a current ratio of 0.92 and a quick ratio of 0.66. The business has a fifty day moving average of $91.41 and a 200-day moving average of $91.33.
Safran Company Profile
Safran SA is a French aerospace and defense company that develops and manufactures equipment, systems and services for commercial aviation, military aircraft, helicopters and space applications. Its activities include aircraft engines, helicopter engines, landing gear, wheels and carbon brakes, engine nacelles, flight-control systems, avionics, navigation equipment and other aerospace systems.
Safran operates several major joint ventures and partnerships, including CFM International with GE Aerospace, which produces the CFM56 and LEAP commercial aircraft engines.
Recommended Stories
- Five stocks we like better than Safran
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for Safran Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safran and related companies with MarketBeat.com's FREE daily email newsletter.
